0001209191-16-125663.txt : 20160603 0001209191-16-125663.hdr.sgml : 20160603 20160603163627 ACCESSION NUMBER: 0001209191-16-125663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160601 FILED AS OF DATE: 20160603 DATE AS OF CHANGE: 20160603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stanley Michael D CENTRAL INDEX KEY: 0001542492 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 161696201 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-01 0 0000893949 MEDNAX, INC. MD 0001542492 Stanley Michael D 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 President, Clinical Services Common Stock 2016-06-01 4 A 0 12135 0.00 A 49266 D Common Stock 2016-06-01 4 S 0 14778 67.7838 D 35247 D Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 3,034 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2016 through March 31, 2017. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2017, June 1, 2018 and June 1, 2019. Sales made pursuant to Reporting Person's 105b-1 trading plan. Sales of shares were made in thirty-seven separate transactions with prices ranging from $67.56 to $67.95 for a weighted average sales price of $67.7838. Includes 759 restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement in excess of target of specified performance-based criteria for the performance period from April 1, 2015 through March 31, 2016, which restricted shares were not previously reported. The additional restricted shares vest in three equal installments on June 1, 2016, June 1, 2017 and June 1, 2018, subject to continued employment. Dominic J. Andreano, Attorney-in-Fact 2016-06-03